Prevention of arthropathy in haemophilia: Prophylaxis

Haemophilia

Volumn 14, Issue SUPPL. 6, 2008, Pages 16-19

  Santagostino, E ^a   Mancuso, M E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Haemophilia; Prophylaxis

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9;

ARTHROPATHY; ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; HEMARTHROSIS; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION;

ADULT; AGE FACTORS; CHILD, PRESCHOOL; COAGULANTS; DRUG ADMINISTRATION SCHEDULE; FACTOR VIII; HEMARTHROSIS; HEMOPHILIA A; HUMANS; INFANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 53249107710     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01884.x     Document Type: Article

References (21)

1. Mannucci PM, Tuddenham EGD. The hemophilias -from Royal genes to gene therapy. N Engl J Med 2001; 344: 1773-9.
2. Aronstam A, Rainsford SG, Painter MJ. Patterns of bleeding in adolescents with severe hemophilia A. Br Med J 1979; 1: 469-70.
3. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007;357: 535-44.
4. Ljung R. Meeting report. Second workshop of the European Paediatric Network for haemophilia management, 17-19 September 1998 in Vitznau/ Switzerland. Haemophilia 1999; 5: 286-91.
5. Berntorp E, Astermark J, Björkman S et al. Consensus perspectives on prophylactic therapy for haemophilia: Summary statement. Haemophilia 2003; 9 (Suppl. 1): 1-4.
6. Donadel-Claeyssens S. Current co-ordinated activities of the PEDNET (European Paediatric Network for Haemophilia Management). Haemophilia 2006; 12: 124-7.
7. Nilsson IM, Berntorp E, Löfqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe hemophilia A and B. J Intern Med 1992; 232: 25-32.
8. Berntorp E, Boulyjenkov V, Brettler D et al. Modern treatment of haemophilia. Bull World Health Organ 1995; 73: 691-701.
9. National Hemophilia Foundation. MASAC Recommendations Concerning Prophylaxis (Regular Administration of Clotting Factor Concentrate to Prevent Bleeding). Available at: http://www.hemophilia.org/NHFWeb/ Resource/StaticPages/menu0/menu5/menu57/masac179.pdf (last accessed on 16 June 2008).
10. World Federation of Hemophilia. Guidelines for the Management of Hemophilia. http://www.wfh.org/2/docs/Publications/ Diagnosis_and_Treatment/Guidelines_Mng_Hemophilia.pdf (last accessed on 16 June 2008)
11. Löfqvist T, Nilsson IM, Berntorp E, Pettersson H. Hemophilic prophylaxis in young patients - a long-term follow-up. J Intern Med 1997; 241: 395-400.
12. Astermark J, Petrini P, Tengborn L, Schulman S, Ljung R, Berntorp E. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Br J Haematol 1999; 105: 1109-13.
13. Petrini P. How to start prophylaxis. Haemophilia 2003; 9 (Suppl. 1): 83-7.
14. Van Creveld S. Prophylaxis of joint hemorrhages in hemophilia. Acta Haematol 1971; 45: 120-7.
15. van den Berg HM, Fischer K, Mauser-Bunschoten EP et al. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br J Haematol 2001; 115: 561-5.
16. Brackmann HH, Eickhoff HJ, Oldenburg J, Hammerstein U. Long-term therapy and on-demand treatment of children and adolescents with severe hemophilia A: 12 years of experience. Haemostasis 1992; 22: 251-8.
17. Schramm W. Experience with prophylaxis in Germany. Semin Hematol 1993; 30: 12-5.
18. Kreuz W, Escuriola-Ettinghausen C, Funk M, Schmidt H, Kornhuber B. When should prophylactic treatment in patients with haemophilia A and B start? -The German experience. Haemophilia 1998; 4: 413-7.
19. Yee TT, Beeton K, Griffioen A, Harrington C, Miners A, Lee CA. Experience of prophylaxis treatment in children with severe haemophilia. Haemophilia 2002; 8: 76-82.
20. Feldman BM, Pai M, Rivard GE et al. Tailored prophylaxis in severe hemophilia A: Interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study. J Thromb Haemost 2006; 4: 1228-36.
21. Gringeri A. Prospective controlled studies on prophylaxis: An Italian approach. Haemophilia 2003; 9 (Suppl. 1): 38-42.